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Background
As the work load for clinical genetics escalates and more
genetic test are ordered, the potential for errors
increase. This report present at the affected patient’s
request, the occurrence of an error and its subsequent
management.
A BRCA2 large deletion had been detected in a family
member and predictive testing had already occurred in
other family members. Our client had 50/50 chance of
having the mutation and had a negative predictive test.
When breast cancer occurred in the patient, the sample
was retested and found to be positive. The different
results were given in person and a root cause analysis
done. The patient requested that the error be discussed
at clinical meetings so lessons found could be learnt by
the whole genetics community.
Multiple factors impacted on this case. An unclassified
variant-considered likely to be benign, had been identi-
fied, as well as a pathogenic mutation. Blood was col-
lected from both relatives one day apart and sent for
testing at the laboratory which identified the mutation.
Although the sample request form requested a predic-
tive test specifying the gene, lab ID and DOB of the pro-
band it did not specify the mutation to avoid
transcription errors. A new laboratory staff member
incorrectly tested for the unclassified variant. Although
duplicate testing was done the samples were not col-
lected independently and the same error occurred. The
clinical staff were rushed as there were 2 carriers in the
breast clinic, one a newly diagnosed breast cancer and
another a possible diagnosis, requesting consultations.
A comprehensive review of the clinic’s genetic testing
protocol has tightened protocol to minimize future
error; the request form is accompanied by a de-identi-
fied copy of the mutation even if the testing laboratory
did the mutation search. Although the protocol required
predictive test results to be checked against the pro-
band’s result results will now be signed by the doctor
and counselor before being given. Cost consideration
are ongoing as to whether the second sample will be
sent completely separately. Efforts are being made to
prevent the clash with the breast clinic.
Errors in genetic testing are rare event and give the
opportunity to review procedures. Knowledge of errors
allow other clinicians to review their protocols. We have
learnt not only from our errors but from the valuable
input from other clinicians who have shared their trau-
matic experiences. We propose that documentation of
the extent and cause of genetic testing errors occur at
the family cancer clinic day next year or at the COSA
meeting. A culture of open disclosure with colleagues as
well as the clients affected will help guard against
further avoidable errors and help us develop sustainable,
attainable and cost effective processes.
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